Brawn Biotech Announces 41st AGM on Sep 29, 2026
Brawn Biotech Ltd has filed its Annual Report for FY 2025-26 and announced the 41st Annual General Meeting (AGM) scheduled for September 29, 2026. The AGM will be conducted via Video Conferencing/Other Audio Visual Means. Key agenda items include the adoption of audited financial statements, re-appointment of a director retiring by rotation, and the appointment of new statutory auditors. The company also detailed the e-voting timelines, with the cut-off date on September 22, 2026, and e-voting open from September 26 to September 28, 2026. Additionally, the AGM notice includes a special business item to approve managerial remuneration for Mr. Amit Kumar, amounting to ₹9,76,512 per annum for three years.
Key Highlights
- Annual Report for FY 2025-26 filed.
- 41st AGM scheduled for September 29, 2026, via VC/OAVM.
- E-voting period: September 26-28, 2026.
- Agenda includes financial statements, director re-appointment, auditor appointment.
- Managerial remuneration for Amit Kumar to be approved.
Price Impact
More from BRAWN